VERU
HEALTHCAREVeru Inc
AI Insight
What's Moving VERU Today?
No stock-specific AI insight has been generated for VERU yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.05$7.25
$3.04
Fundamentals
Market Cap$48M
P/E Ratio—
EPS$-0.80
Dividend Yield—
Dividend / Share—
ROE-51.7%
Profit Margin—
Debt / Equity—
Trading
Volume345K
Avg Volume (10D)—
Shares Outstanding16.1M
VERU News
21 articles- Veru And 2 Other Intriguing Penny Stocks To WatchYahoo Finance·Jun 5, 2026
- Novo Nordisk Tests Wegovy Combinations In Older Adults With Veru TrialYahoo Finance·Jun 5, 2026
- This Small-Cap Biotech Just Soared Over 160% — What Is The Novo Nordisk Connection?Stocktwits·Jun 4, 2026
- Veru Teams Up With Novo Nordisk for Obesity Combination Therapy Trial (VERU)Advfn·Jun 4, 2026
- Earnings call transcript: Veru Inc Q2 2026 shows improved financialsStocktwits·Jun 1, 2026
- Veru Inc (VERU) Q2 2026 Earnings Call Highlights: Promising Clinical Trial Results Amid ...Yahoo Finance·May 13, 2026
- Transcript: Veru Q2 2026 Earnings Conference CallYahoo Finance·May 13, 2026
- Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial ProgressYahoo Finance·May 13, 2026
- Veru Inc. (VERU.US) is scheduled to release its earnings report before the market opens on May 13.富途牛牛·May 7, 2026
- Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13thYahoo Finance·May 6, 2026
- Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight LossYahoo Finance·Mar 9, 2026
- Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences ConferenceYahoo Finance·Feb 19, 2026
- Veru Inc (VERU) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesYahoo Finance·Feb 11, 2026
- Veru Inc. Q1 2026 Earnings Call SummaryMoby·Feb 11, 2026
- Veru (VERU) Q1 2026 Earnings Call TranscriptMotley Fool·Feb 11, 2026
- Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program ProgressYahoo Finance·Feb 11, 2026
- Veru to Report Fiscal 2026 First Quarter Financial Results on February 11thYahoo Finance·Feb 4, 2026
- Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial ChallengesYahoo Finance·Dec 17, 2025
- Veru Reports Fiscal Year 2025 Financial Results and Clinical Program ProgressYahoo Finance·Dec 17, 2025
- Veru to Report Fiscal Year 2025 Financial Results on December 17thYahoo Finance·Dec 10, 2025
- Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory WorkshopYahoo Finance·Dec 4, 2025
All 21 articles loaded
Price Data
Open$2.91
Previous Close$3.04
Day High$3.07
Day Low$2.91
52 Week High$7.25
52 Week Low$2.05
52-Week Range
$2.05$7.25
$3.04
Fundamentals
Market Cap$48M
P/E Ratio—
EPS$-0.80
Dividend Yield—
Dividend / Share—
ROE-51.7%
Profit Margin—
Debt / Equity—
Trading
Volume345K
Avg Volume (10D)—
Shares Outstanding16.1M
About Veru Inc
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—